Remodeling of purinergic receptor-mediated Ca 2+ signaling as a consequence of EGF-induced epithelial-mesenchymal transition in breast cancer cells

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Davis, Felicity M ^a   Kenny, Paraic A ^b   Soo, Eliza T L ^c,d   van Denderen, Bryce J W ^c,d   Thompson, Erik W ^c,d   Cabot, Peter J ^a   Parat, Marie Odile ^a   Roberts Thomson, Sarah J ^a   Monteith, Gregory R ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; CELL MARKER; EPIDERMAL GROWTH FACTOR; IONOTROPIC RECEPTOR; METABOTROPIC RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 2; PURINERGIC P2X RECEPTOR; PURINERGIC P2Y RECEPTOR; PURINERGIC RECEPTOR; VIMENTIN; CALCIUM;

ARTICLE; BREAST CANCER; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CANCER CELL; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; FLUOROMETRY; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IC 50; MEDIAN EFFECTIVE CONCENTRATION; PHENOTYPE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; TRANSCRIPTION REGULATION; BREAST TUMOR; DRUG EFFECT; FEMALE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

BREAST NEOPLASMS; CALCIUM; CELL LINE, TUMOR; EPIDERMAL GROWTH FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; RECEPTORS, PURINERGIC; SIGNAL TRANSDUCTION;

EID: 79961156772     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023464     Document Type: Article

References (54)

1. Polyak K, Weinberg RA, (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9: 265-273.
2. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, et al. (2000) The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2: 76-83.
3. Gilles C, Polette M, Zahm JM, Tournier JM, Volders L, et al. (1999) Vimentin contributes to human mammary epithelial cell migration. J Cell Sci 112: 4615-4625.
4. Lo HW, Hsu SC, Xia W, Cao X, Shih JY, et al. (2007) Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res 67: 9066-9076.
5. Jo M, Lester RD, Montel V, Eastman B, Takimoto S, et al. (2009) Reversibility of epithelial-mesenchymal transition (EMT) induced in breast cancer cells by activation of urokinase receptor-dependent cell signaling. J Biol Chem 284: 22825-22833.
6. Kenny PA, Lee GY, Bissell MJ, (2007) Targeting the tumor microenvironment. Front Biosci 12: 3468-3474.
7. Price JT, Tiganis T, Agarwal A, Djakiew D, Thompson EW, (1999) Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 3′-kinase and phospholipase C-dependent mechanism. Cancer Res 59: 5475-5478.
8. Goswami S, Sahai E, Wyckoff J, Cammer M, Cox D, et al. (2005) Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res 65: 5278-5283.
9. Joyce JA, Pollard JW, (2009) Microenvironmental regulation of metastasis. Nat Rev Cancer 9: 239-252.
10. Suzuki M, Mose ES, Montel V, Tarin D, (2006) Dormant cancer cells retrieved from metastasis-free organs regain tumorigenic and metastatic potency. Am J Pathol 169: 673-681.
11. House SJ, Potier M, Bisaillon J, Singer HA, Trebak M, (2008) The non-excitable smooth muscle: calcium signaling and phenotypic switching during vascular disease. Pflugers Arch 456: 769-785.
12. Chen CN, Li YS, Yeh YT, Lee PL, Usami S, et al. (2006) Synergistic roles of platelet-derived growth factor-BB and interleukin-1beta in phenotypic modulation of human aortic smooth muscle cells. Proc Natl Acad Sci U S A 103: 2665-2670.
13. Neylon CB, Avdonin PV, Dilley RJ, Larsen MA, Tkachuk VA, et al. (1994) Different electrical responses to vasoactive agonists in morphologically distinct smooth muscle cell types. Circ Res 75: 733-741.
14. Clapham DE, (2007) Calcium signaling. Cell 131: 1047-1058.
15. Monteith GR, McAndrew D, Faddy HM, Roberts-Thomson SJ, (2007) Calcium and cancer: targeting Ca2+ transport. Nat Rev Cancer 7: 519-530.
16. Yang S, Zhang JJ, Huang XY, (2009) Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Cancer Cell 15: 124-134.
17. Coughlin SR, (2000) Thrombin signalling and protease-activated receptors. Nature 407: 258-264.
18. Bohm SK, Kong W, Bromme D, Smeekens SP, Anderson DC, et al. (1996) Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. Biochem J 314: 1009-1016.
19. Morris DR, Ding Y, Ricks TK, Gullapalli A, Wolfe BL, et al. (2006) Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells. Cancer Res 66: 307-314.
20. Charafe-Jauffret E, Ginestier C, Monville F, Finetti P, Adelaide J, et al. (2006) Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene 25: 2273-2284.
21. White N, Burnstock G, (2006) P2 receptors and cancer. Trends Pharmacol Sci 27: 211-217.
22. Khakh BS, Burnstock G, Kennedy C, King BF, North RA, et al. (2001) International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev 53: 107-118.
23. von Kugelgen I, (2006) Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther 110: 415-432.
24. Pellegatti P, Raffaghello L, Bianchi G, Piccardi F, Pistoia V, et al. (2008) Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS One 3: e2599.
25. Bilbao PS, Santillan G, Boland R, (2010) ATP stimulates the proliferation of MCF-7 cells through the PI3K/Akt signaling pathway. Arch Biochem Biophys 499: 40-48.
26. Thiery JP, Sleeman jP, (2006) Complex networds orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131-142.
27. Leinonen P, Aaltonen V, Koskela S, Lehenkari P, Korkiamäki T, et al. (2007) Impaired Gap Junction Formation and Intercellular Calcium Signaling in Urinary Bladder Cancer Cells can be Improved by Gö6976. Cell Commun Adhes 14: 125.
28. Hugo HJ, Kokkinos MI, Blick T, Ackland ML, Thompson EW, et al. (2011) Defining the E-cadherin repressor interactome in epithelial-mesenchymal transition: the PMC42 model as a case study. Cells Tissues Organs 193: 23-40.
29. Kenny PA, Lee GY, Myers CA, Neve RM, Semeiks JR, et al. (2007) The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol 1: 84-96.
30. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999-2009.
31. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, et al. (2000) Molecular portraits of human breast tumours. Nature 406: 747-752.
32. Sarrio D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, et al. (2008) Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 68: 989-997.
33. Weigelt B, Peterse JL, van 't Veer LJ, (2005) Breast cancer metastasis: markers and models. Nat Rev Cancer 5: 591-602.
34. Fidler IJ, (2003) The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3: 453-458.
35. Zhang Y, Gong LH, Zhang HQ, Du Q, You JF, et al. (2010) Extracellular ATP enhances in vitro invasion of prostate cancer cells by activating Rho GTPase and upregulating MMPs expression. Cancer Lett 293: 189-197.
36. Shabbir M, Ryten M, Thompson C, Mikhailidis D, Burnstock G, (2008) Characterization of calcium-independent purinergic receptor-mediated apoptosis in hormone-refractory prostate cancer. BJU Int 101: 352-359.
37. Erlinge D, Burnstock G, (2008) P2 receptors in cardiovascular regulation and disease. Purinergic Signal 4: 1-20.
38. Erlinge D, Hou M, Webb TE, Barnard EA, Moller S, (1998) Phenotype changes of the vascular smooth muscle cell regulate P2 receptor expression as measured by quantitative RT-PCR. Biochem Biophys Res Commun 248: 864-870.
39. Bo X, Jiang LH, Wilson HL, Kim M, Burnstock G, et al. (2003) Pharmacological and biophysical properties of the human P2X5 receptor. Mol Pharmacol 63: 1407-1416.
40. Jarvis MF, Khakh BS, (2009) ATP-gated P2X cation-channels. Neuropharmacology 56: 208-215.
41. Soroceanu L, Manning TJ Jr, Sontheimer H, (1999) Modulation of glioma cell migration and invasion using Cl- and K+ ion channel blockers. J Neurosci 19: 5942-5954.
42. Ryten M, Dunn PM, Neary JT, Burnstock G, (2002) ATP regulates the differentiation of mammalian skeletal muscle by activation of a P2X5 receptor on satellite cells. J Cell Biol 158: 345-355.
43. Voulgari A, Pintzas A, (2009) Epithelial-mesenchymal transition in cancer metastasis: Mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta 1796: 75-90.
44. Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, et al. (2001) Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci U S A 98: 10356-10361.
45. Mejlvang J, Kriajevska M, Vandewalle C, Chernova T, Sayan AE, et al. (2007) Direct repression of cyclin d1 by SIP1 attenuates cell cycle progression in cells undergoing an epithelial mesenchymal transition. Mol Biol Cell 18: 4615-4624.
46. Smid M, Wang Y, Zhang Y, Sieuwerts AM, Yu J, et al. (2008) Subtypes of breast cancer show preferential site of relapse. Cancer Res 68: 3108-3114.
47. Prat A, Parker JS, Karginova O, Fan C, Livasy C, et al. (2010) Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 12: R68.
48. Blick T, Widodo E, Hugo H, Waltham M, Lenburg ME, et al. (2008) Epithelial mesenchymal transition traits in human breast cancer cell lines. Clin Exp Metastasis 25: 629-642.
49. Ackland ML, Newgreen DF, Fridman M, Waltham MC, Arvanitis A, et al. (2003) Epidermal growth factor-induced epithelio-mesenchymal transition in human breast carcinoma cells. Lab Invest 83: 435-448.
50. Aung CS, Kruger WA, Poronnik P, Roberts-Thomson SJ, Monteith GR, (2007) Plasma membrane Ca2+-ATPase expression during colon cancer cell line differentiation. Biochem Biophys Res Commun 355: 932-936.
51. Grice DM, Vetter I, Faddy HM, Kenny PA, Roberts-Thomson SJ, et al. (2010) Golgi calcium pump secretory pathway calcium ATPase 1 (SPCA1) is a key regulator of insulin-like growth factor receptor (IGF1R) processing in the basal-like breast cancer cell line MDA-MB-231. J Biol Chem 285: 37458-37466.
52. Suchanek KM, May FJ, Robinson JA, Lee WJ, Holman NA, et al. (2002) Peroxisome proliferator-activated receptor alpha in the human breast cancer cell lines MCF-7 and MDA-MB-231. Mol Carcinog 34: 165-171.
53. Briand P, Petersen OW, Van Deurs B, (1987) A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium. In Vitro Cell Dev Biol 23: 181-188.
54. Briand P, Nielsen KV, Madsen MW, Petersen OW, (1996) Trisomy 7p and malignant transformation of human breast epithelial cells following epidermal growth factor withdrawal. Cancer Res 56: 2039-2044.